140 related articles for article (PubMed ID: 2571321)
1. Reversal of leukotriene D4- and leukotriene E4-induced airway constriction in the guinea pig.
Silbaugh SA; Stengel PW; Pechous PA; Marshall WS
Am Rev Respir Dis; 1989 Sep; 140(3):610-4. PubMed ID: 2571321
[TBL] [Abstract][Full Text] [Related]
2. The pharmacological evaluation of LY 170680, a novel leukotriene D4 and E4 antagonist in the guinea-pig.
Boot JR; Bond A; Gooderham R; O'Brien A; Parsons M; Thomas KH
Br J Pharmacol; 1989 Sep; 98(1):259-67. PubMed ID: 2553189
[TBL] [Abstract][Full Text] [Related]
3. Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors.
Aharony D; Catanese CA; Falcone RC
J Pharmacol Exp Ther; 1989 Feb; 248(2):581-8. PubMed ID: 2537402
[TBL] [Abstract][Full Text] [Related]
4. Reversal of A23187-induced airway constriction in the guinea pig.
Stengel PW; Silbaugh SA
J Pharmacol Exp Ther; 1989 Mar; 248(3):1084-90. PubMed ID: 2495351
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of LTD4-mediated bronchopulmonary effects by salbutamol.
Woodward DF; Weichman BM; Wasserman MA
Eur J Pharmacol; 1984 Apr; 100(2):219-22. PubMed ID: 6734717
[TBL] [Abstract][Full Text] [Related]
6. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
Mong S; Wu HL; Miller J; Hall RF; Gleason JG; Crooke ST
Mol Pharmacol; 1987 Aug; 32(1):223-9. PubMed ID: 3039338
[TBL] [Abstract][Full Text] [Related]
7. Functional antagonism by salbutamol suggests differences in the relative efficacies and dissociation constants of the peptidoleukotrienes in guinea pig trachea.
Hay DW; Muccitelli RM; Wilson KA; Wasserman MA; Torphy TJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):71-8. PubMed ID: 2826775
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-([4- (1H-tetrazol-5-ylmethyl)phenoxy]methyl) phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4.
Fleisch JH; Rinkema LE; Haisch KD; McCullough D; Carr FP; Dillard RD
Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):70-7. PubMed ID: 3016562
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors.
Lee TH; Austen KF; Corey EJ; Drazen JM
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4922-5. PubMed ID: 6087352
[TBL] [Abstract][Full Text] [Related]
10. The effect of an orally active leukotriene D4/E4 antagonist, LY171883, on antigen-induced airway responses in allergic sheep.
Abraham WM; Wanner A; Stevenson JS; Chapman GA
Prostaglandins; 1986 Mar; 31(3):457-67. PubMed ID: 3754973
[TBL] [Abstract][Full Text] [Related]
11. Systemic and regional hemodynamic effects of leukotrienes D4 and E4 in the conscious rat.
Eimerl J; Sirén AL; Feuerstein G
Am J Physiol; 1986 Oct; 251(4 Pt 2):H700-9. PubMed ID: 3021000
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of leukotrienes E4, N-acetyl E4 and of four of their novel omega- and beta-oxidative metabolites in airways of guinea-pig and man in vitro.
Samhoun MN; Conroy DM; Piper PJ
Br J Pharmacol; 1989 Dec; 98(4):1406-12. PubMed ID: 2558763
[TBL] [Abstract][Full Text] [Related]
13. Primate myocardial and systemic hemodynamic responses to leukotriene D4: antagonism by LY171883.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1987 Jul; 242(1):62-9. PubMed ID: 3612538
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of leukotrienes C4, D4, and E4 in the pulmonary and systemic vasculature of sheep.
Ahmed T; Marchette B; Wasserman M; Wanner A; Yerger L
Bull Eur Physiopathol Respir; 1986; 22(6):573-80. PubMed ID: 3030470
[TBL] [Abstract][Full Text] [Related]
15. Leukotrienes: possible mediators in bronchial asthma.
Piper PJ
Eur J Respir Dis Suppl; 1983; 129():45-64. PubMed ID: 6317422
[TBL] [Abstract][Full Text] [Related]
16. Conscious guinea-pig aerosol model for evaluation of peptide leukotriene antagonists.
Snyder DW; Liberati NJ; McCarthy MM
J Pharmacol Methods; 1988 May; 19(3):219-31. PubMed ID: 2839739
[TBL] [Abstract][Full Text] [Related]
17. 2-nor-leukotriene analogs: antagonists of the airway and vascular smooth muscle effects of leukotriene C4, D4 and E4.
Gleason JG; Ku TW; McCarthy ME; Weichman BM; Holden D; Osborn RR; Zabko-Potapovich B; Berkowitz B; Wasserman MA
Biochem Biophys Res Commun; 1983 Dec; 117(3):732-9. PubMed ID: 6320814
[TBL] [Abstract][Full Text] [Related]
18. In vivo pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist.
Krell RD; Giles RE; Yee YK; Snyder DW
J Pharmacol Exp Ther; 1987 Nov; 243(2):557-64. PubMed ID: 2824752
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene receptor antagonism and augmentation of beta-receptor-mediated events by LY171883.
Rinkema LE; Roman CR; Russell WL; Spaethe SM; Bemis KG; Henry DP; Marshall WS; Fleisch JH
J Pharm Pharmacol; 1990 Sep; 42(9):620-5. PubMed ID: 1706765
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene receptor antagonists. 4. Synthesis and leukotriene D4/E4 receptor antagonist activity of 4-(alkyl)acetophenone derivatives.
Gapinski DM; Roman CR; Rinkema LE; Fleisch JH
J Med Chem; 1988 Jan; 31(1):172-5. PubMed ID: 2826785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
